Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM1 | P11229 | 1/20 | 0.38 |
| ▸ | PTH1R | Q03431 | 6/20 | 0.36 |
| ▸ | CES1 | P23141 | 1/20 | 0.33 |
| ▸ | HSD11B1 | P28845 | 3/20 | 0.33 |
| ▸ | PSD | A5PKW4 | 2/20 | 0.33 |
| ▸ | CNR2 | P34972 | 2/20 | 0.33 |
| ▸ | HSD11B2 | P80365 | 1/20 | 0.32 |
| ▸ | ARF6 | P62330 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5320857 | 0.88 | PTH1R (0.36) | CHRM1PTH1RCNR2ARF6 | |
| SCHEMBL5323969 | 0.88 | LMNA (0.31) | CNR2 | |
| SCHEMBL5321521 | 0.86 | PTH1R (0.38) | PTH1R | |
| SCHEMBL5331877 | 0.86 | CES2 (0.32) | PTH1RCNR2 | |
| SCHEMBL5327710 | 0.85 | ALDH1A1 (0.33) | PTH1RCNR2 | |
| SCHEMBL5354194 | 0.82 | PTH1R (0.39) | CHRM1PTH1RCES1HSD11B1CNR2 | |
| SCHEMBL5349124 | 0.80 | CNR2 (0.31) | CNR2 | |
| SCHEMBL5330541 | 0.78 | PTH1R (0.37) | CHRM1PTH1RCNR2 | |
| SCHEMBL5319651 | 0.77 | PTH1R (0.37) | CHRM1PTH1RARF6 | |
| SCHEMBL5349032 | 0.77 | PTH1R (0.49) | CHRM1PTH1RCES1HSD11B1HSD11B2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2006129120-A9 | BENZOTRIAZEPINONE DERIVATIVES | JAMES BLACK FOUNDATION (GB) | 2007-03-22 | — | — | WO | disclosed |
| WO-2006129120-A2 | BENZOTRIAZEPINONE DERIVATIVES | JAMES BLACK FOUNDATION (GB) | 2006-12-07 | — | — | WO | disclosed |